These findings were supported by a clear trend to an infiltrative growth and a higher probability of recurrence in HCC cases when overexpressing FGF9 (Figure 3C) as well as by reports on models of various cancer entities.19, 21, 24, 25. This evidence concerns the gene FGF9 and hepatocellular carcinoma.